AI assistant
SKIN ELEMENTS LIMITED — Capital/Financing Update 2025
Dec 14, 2025
65803_rns_2025-12-14_96c1f730-83ec-4de1-9241-a542fe882fad.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
Appendix 2A - Application for quotation of securities
==> picture [21 x 22] intentionally omitted <==
Announcement Summary
Entity name
SKIN ELEMENTS LIMITED
Announcement Type
New announcement
Date of this announcement
Monday December 15, 2025
The +securities to be quoted are: Other
Please refer to the response to Q2.3d for further information about the type of securities to be quoted and the circumstances of the issue.
were subject to shareholder approval on 28 Nov 2025, which has now been received.
Total number of +securities to be quoted
| ASX +security | Number of +securities to | ||
|---|---|---|---|
| code | Security description | be quoted | Issue date |
| SKN | ORDINARY FULLY PAID | 500,000,000 | 12/12/2025 |
Refer to next page for full details of the announcement
Appendix 2A - Application for quotation of securities
1 / 6
Appendix 2A - Application for quotation of securities
Part 1 - Entity and announcement details
==> picture [21 x 22] intentionally omitted <==
1.1 Name of entity
SKIN ELEMENTS LIMITED
We (the entity named above) apply for +quotation of the following +securities and agree to the matters set out in Appendix 2A of the ASX Listing Rules.
1.2 Registered number type
ACN
Registration number
608047794
1.3 ASX issuer code
SKN
1.4 The announcement is
New announcement
1.5 Date of this announcement
15/12/2025
Appendix 2A - Application for quotation of securities
2 / 6
Appendix 2A - Application for quotation of securities
==> picture [21 x 22] intentionally omitted <==
Part 2 - Type of Issue
2.1 The +securities to be quoted are:
Other
Please refer to the response to Q2.3d for further information about the type of securities to be quoted and the circumstances of the issue.
2.2 The +class of +securities to be quoted is:
Additional +securities in a class that is already quoted on ASX ("existing class")
2.3c Have these +securities been offered under a +disclosure document or +PDS? No
2.3d Please provide any further information needed to understand the circumstances in which you are applying to have these +securities quoted on ASX, including why the issue of the +securities has not been previously announced to the market in an Appendix 3B
were subject to shareholder approval on 28 Nov 2025, which has now been received.
2.4 Any on-sale of the +securities to be quoted within 12 months of their date of issue will comply with the secondary sale provisions in sections 707(3) and 1012C(6) of the Corporations Act by virtue of: The publication of a cleansing notice under section 708A(5), 708AA(2)(f), 1012DA(5) or 1012DAA(2)(f)
Appendix 2A - Application for quotation of securities
3 / 6
Appendix 2A - Application for quotation of securities
==> picture [21 x 22] intentionally omitted <==
Part 3B - number and type of +securities to be quoted (existing class) where issue has not previously been notified to ASX in an Appendix 3B
Additional +securities to be quoted in an existing class ASX +security code and description SKN : ORDINARY FULLY PAID Issue date 12/12/2025 Will the +securities to be quoted rank equally in all respects from their issue date with the existing issued +securities in that class? Yes Issue details Number of +securities to be quoted 500,000,000 Are the +securities being issued for a cash consideration? No Please describe the consideration being provided for the +securities in lieu of unpaid director fees to Peter Malone and partial salary accrual but unpaid to Leo Fung Please provide an estimate (in AUD) of the value of the consideration being provided per +security for the +securities to be quoted 0.002000 Any other information the entity wishes to provide about the +securities to be quoted The purpose(s) for which the entity is issuing the securities To pay for services rendered Please provide additional details issued in accordance with shareholder approval 28 Nov 2025 Resolution 3 and 4
Appendix 2A - Application for quotation of securities
4 / 6
Appendix 2A - Application for quotation of securities
==> picture [21 x 22] intentionally omitted <==
Part 4 - Issued capital following quotation
Following the quotation of the +securities the subject of this application, the issued capital of the entity will comprise:
The figures in parts 4.1 and 4.2 below are automatically generated and may not reflect the entity's current issued capital if other Appendix 2A, Appendix 3G or Appendix 3H forms are currently with ASX for processing.
4.1 Quoted +securities (total number of each +class of +securities quoted on ASX following the +quotation of the +securities subject of this application)
+securities subject of this application) |
|
|---|---|
| Total number of | |
| ASX +security code and description | +securities on issue |
| SKNOD : OPTION EXPIRING 31-MAY-2026 | 133,351,198 |
| SKN : ORDINARY FULLY PAID | 2,825,214,115 |
4.2 Unquoted +securities (total number of each +class of +securities issued but not quoted on ASX)
| Total number of | |
|---|---|
| ASX +security code and description | +securities on issue |
| SKNAS : OPTION EXPIRING 31-OCT-2025 EX $0.05 | 28,000,000 |
| SKNAU : PERFORMANCE SHARES CLASS A | 100,000,000 |
| SKNAV : PERFORMANCE SHARES CLASS B | 62,000,000 |
| SKNAX : OPTION EXPIRING 21-FEB-2028 EX $0.01 | 219,061,355 |
Appendix 2A - Application for quotation of securities
5 / 6
Appendix 2A - Application for quotation of securities
==> picture [21 x 22] intentionally omitted <==
Part 5 - Other Listing Rule requirements
5.1 Are the +securities being issued under an exception in Listing Rule 7.2 and therefore the issue does not need any security holder approval under Listing Rule 7.1? No
5.2 Has the entity obtained, or is it obtaining, +security holder approval for the issue under listing rule 7.1? Yes
5.2a Date of meeting or proposed meeting to approve the issue under listing rule 7.1
28/11/2025
Appendix 2A - Application for quotation of securities
6 / 6